ABN AMRO Bank N.V. Acquires New Position in Cardinal Health, Inc. $CAH

ABN AMRO Bank N.V. acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 11,605 shares of the company’s stock, valued at approximately $2,427,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Pinnacle Wealth Management Advisory Group LLC purchased a new position in shares of Cardinal Health in the first quarter worth about $204,000. GHP Investment Advisors Inc. lifted its stake in shares of Cardinal Health by 0.5% during the 1st quarter. GHP Investment Advisors Inc. now owns 38,491 shares of the company’s stock valued at $8,133,000 after buying an additional 179 shares in the last quarter. LifeWealth Investments LLC boosted its holdings in Cardinal Health by 8.6% in the 1st quarter. LifeWealth Investments LLC now owns 1,167 shares of the company’s stock worth $247,000 after buying an additional 92 shares during the period. Louisiana State Employees Retirement System bought a new position in Cardinal Health in the 1st quarter worth approximately $2,536,000. Finally, Fairvoy Private Wealth LLC purchased a new position in Cardinal Health in the 1st quarter valued at approximately $561,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Cardinal Health stock opened at $237.89 on Monday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $240.44. The stock has a market cap of $55.72 billion, a P/E ratio of 36.38, a PEG ratio of 1.30 and a beta of 0.52. The firm’s fifty day moving average price is $206.07 and its 200-day moving average price is $210.39.

Cardinal Health (NYSE:CAHGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the company earned $2.35 earnings per share. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is 31.19%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CAH shares. William Blair began coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Evercore dropped their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Finally, Citigroup decreased their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $246.93.

Get Our Latest Stock Report on CAH

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.